Johan Sandell

Johan Sandell is the CEO of Novandi Chemistry AB since January 2013. Prior to this role, Johan held positions as Associate Director/Team leader at AstraZeneca R&D and Senior Scientist at various companies. Johan has a diverse educational background, with degrees in Chemical Engineering, Experimental Neuroscience, and Positron Emission Tomography. Johan specializes in the synthesis and labeling of drug candidates and radioligands for imaging purposes.